Literature DB >> 23010581

Durability of pericardial versus porcine bioprosthetic heart valves.

Gary L Grunkemeier1, Anthony P Furnary, YingXing Wu, Lian Wang, Albert Starr.   

Abstract

OBJECTIVES: To compare the probability, and modes, of explantation for Carpentier-Edwards pericardial versus porcine valves.
METHODS: Our porcine series began in 1974 and our pericardial series in 1991, with annual prospective follow-up. We used the Kaplan-Meier method and Cox regression for estimation and analysis of patient mortality, and the cumulative incidence function and competing risks regression for estimation and analysis of valve durability.
RESULTS: Through the end of 2010, we had implanted 506 porcine and 2449 pericardial aortic valves and 181 porcine and 163 pericardial mitral valves. The corresponding total and maximum follow-up years were 3471 and 24, 11,517 and 18, 864 and 22, and 645 and 9. The corresponding probabilities (cumulative incidence function) of any valve explant were 7%, 8%, 22%, and 8%, and of explant for structural valve deterioration were 4%, 5%, 16%, and 5% at 15 years for the first 3 series and at 8 years for the fourth (pericardial mitral valve) series. Using competing risks regression for structural valve deterioration explant, with age, gender, valve size, and concomitant coronary bypass surgery as covariates, a slight (subhazard ratio, 0.79), but nonsignificant, protective effect was found for the pericardial valve in the aortic position and a greater (subhazard ratio, 0.31) and almost significant (P = .08) protective effect of the pericardial valve in the mitral position. Leaflet tear was responsible for 61% of the structural valve deterioration explants in the porcine series and 46% in the pericardial series.
CONCLUSIONS: Using competing risks regression, the pericardial valve had a subhazard ratio for structural valve deterioration explant of less than 1 in both positions, approaching statistical significance in the mitral position. The mode of structural valve deterioration was predominantly leaflet tear for porcine valves and fibrosis/calcification for pericardial valves.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23010581     DOI: 10.1016/j.jtcvs.2012.08.060

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

Review 1.  The Use of Biological Heart Valves.

Authors:  Sami Kueri; Fabian A Kari; Rafael Ayala Fuentes; Hans-Hinrich Sievers; Friedhelm Beyersdorf; Wolfgang Bothe
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

2.  Shifting paradigms for treatment of symptomatic aortic stenosis in lower risk populations: role of a newer generation balloon-expandable transcatheter aortic valve implantation device.

Authors:  Erik Walter Holy; Mohamed Abdel-Wahab
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

3.  eComment. The current bioprosthesis of choice for aortic valve replacements.

Authors:  Jamil Hajj-Chahine
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03

Review 4.  Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review.

Authors:  Reza Tavakoli; Pichoy Danial; Ahmed Hamid Oudjana; Peiman Jamshidi; Max Gassmann; Pascal Leprince; Guillaume Lebreton
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-01-10

Review 5.  Prosthetic cardiac valves: history and review of cardiac prostheses clinically available in Japan.

Authors:  Eiki Tayama; Kosuke Saku; Tomoyuki Anegawa; Atsunobu Oryoji; Shinya Negoto
Journal:  Surg Today       Date:  2021-08-25       Impact factor: 2.549

6.  Very-long-term outcomes of mechanical valves in mitral position focusing on valve-related complications.

Authors:  Gaku Uchino; Hirohisa Murakami; Nobuhiko Mukohara; Hiroshi Tanaka; Yoshikatsu Nomura; Shunsuke Miyahara; Motoharu Kawashima; Jun Fujisue; Shuto Tonoki
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

7.  Intermediate-term outcomes after aortic valve replacement with a novel RESILIATM tissue bioprosthesis.

Authors:  Krzysztof Bartus; Radoslaw Litwinowicz; Agata Bilewska; Maciej Stapor; Maciej Bochenek; Jacek Rozanski; Jerzy Sadowski; Grzegorz Filip; Boguslaw Kapelak; Mariusz Kusmierczyk
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

8.  The Additional Value of Three-Dimensional Transesophageal Echocardiography in the Diagnosis of Unusual Complication of Bioprosthetic Mitral Valve.

Authors:  Martina Evangelista; Marta Barletta; Anca Irina Corciu; Valnetina Mantovani; Lucrezia Delli Paoli; Marco Guazzi; Maurizio Tusa
Journal:  J Cardiovasc Echogr       Date:  2019 Apr-Jun

Review 9.  Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation.

Authors:  Pier Pasquale Leone; Fabio Fazzari; Francesco Cannata; Jorge Sanz-Sanchez; Antonio Mangieri; Lorenzo Monti; Ottavia Cozzi; Giulio Giuseppe Stefanini; Renato Bragato; Antonio Colombo; Bernhard Reimers; Damiano Regazzoli
Journal:  Front Cardiovasc Med       Date:  2021-06-04

10.  Biomaterial characterization of off-the-shelf decellularized porcine pericardial tissue for use in prosthetic valvular applications.

Authors:  Joshua A Choe; Soumen Jana; Brandon J Tefft; Ryan S Hennessy; Jason Go; David Morse; Amir Lerman; Melissa D Young
Journal:  J Tissue Eng Regen Med       Date:  2018-05-30       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.